<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Nova farmakovigilančna zakonodaja in vpliv na regulatorno prakso</dc:title><dc:creator>Bajrić Sadiković,	Mirela	(Avtor)
	</dc:creator><dc:creator>Srčič,	Stanko	(Mentor)
	</dc:creator><dc:creator>Milošev Tuševljak,	Smiljana	(Komentor)
	</dc:creator><dc:subject>farmakovigilanca</dc:subject><dc:subject>neželeni učinki zdravil</dc:subject><dc:subject>varnost zdravil</dc:subject><dc:subject>promet z zdravili</dc:subject><dc:subject/><dc:publisher>[M. Bajrić Sadiković]</dc:publisher><dc:date>2014</dc:date><dc:date>2015-07-10 22:09:02</dc:date><dc:type>Diplomsko delo</dc:type><dc:identifier>71525</dc:identifier><dc:identifier>UDK: 340.134:615.01(043.2)</dc:identifier><dc:identifier>COBISS_ID: 3779953</dc:identifier><dc:language>sl</dc:language></metadata>
